Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM-700C in Naive Genotype 1 Hepatitis C
NCT01890200Phase 3Withdrawn
- Sponsor
- TCM Biotech International Corp.
- Start
- Jun 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Compound Cordyceps TCM-700C in hepatitis C (HCV), sponsored by TCM Biotech International Corp.. Planned start Jun 2015; status: withdrawn.
02
Drugs
Compound Cordyceps TCM-700C
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01890200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890200.